Evidence map›Paper›PMID 33143166›Full record

ArticleMedicina (Kaunas, Lithuania)2020

Ustekinumab Drug Survival in Patients with Psoriasis: A retrospective Study of Real Clinical Practice.

Cristina Galache Osuna, Borja Gómez-Vila, Javier Aubán Pariente, Beatriz Vázquez Losada, Celia Gómez de Castro, Sheila Requena López, Álvaro de Dios Velázquez, Laura Palacios García, Lucía Ordoñez Fernández, Santiago Gómez Diez and 2 more

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cristina Galache OsunaDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Borja Gómez-VilaDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-8279-1648
Javier Aubán ParienteDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Beatriz Vázquez LosadaDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Celia Gómez de CastroDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Sheila Requena LópezDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Álvaro de Dios VelázquezDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Laura Palacios GarcíaDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Lucía Ordoñez FernándezClinical Management Unit, UGC Farmacia, Hospital Universitario Central de Asturias, 33011 Oviedo, Asturias, Spain.
Santiago Gómez DiezDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Francisco Vázquez LópezDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Jorge Santos-JuanesDepartment of Dermatology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0001-5578-3522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pharmaceutical PreparationsPsoriasisAdalimumabHumansRetrospective StudiesTreatment OutcomeUstekinumabAdalimumabPharmaceutical PreparationsUstekinumabbiological treatmentinterleukin drug survivalpsoriasisustekinumab

Identifiers

PMID33143166
PMCPMC7693782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.